Article Details
Retrieved on: 2021-04-01 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... continued development of the Company's proposed transdermal delivery technology for hydroxychloroquine (HCQ), as first announced in April 2020.
Article found on: investingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here